Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects

Clinica Chimica Acta

Volumn 403, Issue 1-2, 2009, Pages 97-101

  Li, Hung Yuan ^a,b   Lin, Mao Shin ^a,b   Wei, Jung Nan ^c   Hung, Chi Sheng ^a   Chiang, Fu Tien ^a   Lin, Cheng Hsin ^d   Hsu, Hsiu Ching ^a   Su, Chien Yin ^a   Wu, Mei Yu ^a   Smith, David J ^e   Vainio, Jani ^e   Chen, Ming Fong ^a   Chuang, Lee Ming ^a,b,f  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e Biotie Therapies Corp   (Finland)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Advanced glycated end products; Carotid intima medial thickness; Oxidative stress; Vascular adhesion protein 1

Indexed keywords

ADVANCED GLYCATION END PRODUCT; C REACTIVE PROTEIN; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VASCULAR ADHESION PROTEIN 1;

ADULT; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INTIMA; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TUNICA MEDIA; ULTRASOUND;

AMINE OXIDASE (COPPER-CONTAINING); ATHEROSCLEROSIS; CAROTID ARTERIES; CELL ADHESION MOLECULES; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; TUNICA INTIMA;

EID: 64849117833     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.01.027     Document Type: Article

References (27)

1. Mbanya J.C., Gan D., Allgot B., Bakker K., Brown J.B., Ramachandran A., et al. Diabetes Atlas, Third ed. Brussels (2006), International Diabetes Federation, Belgium:
2. Khaw K.T., Wareham N., Bingham S., Luben R., Welch A., and Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141 (2004) 413-420
3. Hanefeld M., Koehler C., Schaper F., Fuecker K., Henkel E., and Temelkova-Kurktschiev T. Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atherosclerosis 144 (1999) 229-235
4. Salmi M., and Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 257 (1992) 1407-1409
5. Merinen M., Irjala H., Salmi M., Jaakkola I., Hanninen A., and Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol 166 (2005) 793-800
6. Mazzone T., Chait A., and Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371 (2008) 1800-1809
7. Yu P.H., Wright S., Fan E.H., Lun Z.R., and Gubisne-Harberle D. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 1647 (2003) 193-199
8. Jalkanen S., and Salmi M. Cell surface monoamine oxidases: enzymes in search of a function. EMBO J 20 (2001) 3893-3901
9. Salmi M., Stolen C., and Jousilahti P. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol 161 (2002) 2255-2262
10. Adams D.H., Mainolfi E., and Burra P. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 16 (1992) 810-814
11. Bloom S., Fleming K., and Chapman R. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis. Gut 36 (1995) 604-609
12. Monnier L., Mas E., and Ginet C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
13. Bonnefont D., Legrand A., Peynet J., Emerit J., Delattre J., and Galli A. Distribution of thiobarbituric acid-reactive substances in lipoproteins and proteins in serum. Clin Chem 35 (1989) 2054-2058
14. Yu P.H., and Zuo D.M. Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia 40 (1997) 1243-1250
15. Lin M.S., Li H.Y., and Wei J.N. Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. Clin Biochem (2008)
16. Meszaros Z., Karadi I., Csanyi A., Szombathy T., Romics L., and Magyar K. Determination of human serum semicarbazide-sensitive amine oxidase activity: a possible clinical marker of atherosclerosis. Eur J Drug Metab Pharmacokinet 24 (1999) 299-302
17. Holmlund A., Hulthe J., Millgard J., Sarabi M., Kahan T., and Lind L. Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals. Atherosclerosis 165 (2002) 271-276
18. Abella A., Marti L., and Camps M. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki Rats. Diabetes 52 (2003) 1004-1013
19. Reaven M.G. Insulin resistance and its consequences - type 2 diabetes mellitus and the insulin resistance syndrome. In: LeRoith D., Taylor I.S., and Olefsky J.M. (Eds). Diabetes mellitus: a fundamental and clinical text. 3rd ed (2004), LIPPINCOTT WILLIAMS & WILKINS, Philadelphia 899-916
20. Boomsma F., van den Meiracker A.H., and Winkle S. Circulating semicarbazide-sensitive amine oxidase is raised both in type I (insulin-dependent), in type II (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis. Diabetologia 42 (1999) 233-237
21. Meszaros Z., Szombathy T., Raimondi L., Karadi I., Romics L., and Magyar K. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism 48 (1999) 113-117
22. Garpenstrand H., Ekblom J., Backlund L.B., Oreland L., and Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet Med 16 (1999) 514-521
23. Jaakkola K., Jalkanen S., Kaunismaki K., et al. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol 36 (2000) 122-129
24. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352:837-53.
25. Bonora E., and Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 44 (2001) 2107-2114
26. Stolen C.M., Yegutkin G.G., Kurkijarvi R., Bono P., Alitalo K., and Jalkanen S. Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 95 (2004) 50-57
27. Abella A., Garcia-Vicente S., Viguerie N., et al. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47 (2004) 429-438